441P - OT-1096: A first-in-class immunoactivating small molecule that targets the thioredoxin reductase/thioredoxin axis causes strong tumor growth inhibition by downregulating intratumoral tregs in a humanized TNBC-PDX model
Autor: | Orwar, O., Lowstedt, I., Andersson, K., Gannedahl, G., Willman, G., Davidsson, M., Stafford, W., Trkulja, C. |
---|---|
Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
Databáze: | ScienceDirect |
Externí odkaz: |